Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)

about

Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)

Item

http://www.wikidata.org/entity/Q57298259

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 23 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Genotype and Lifetime Burden o ...... ardiomyopathy Registry (SHaRe)

@en

Genotype and Lifetime Burden o ...... Human Cardiomyopathy Registry

@nl

type

Item

label

Genotype and Lifetime Burden o ...... ardiomyopathy Registry (SHaRe)

@en

Genotype and Lifetime Burden o ...... Human Cardiomyopathy Registry

@nl

prefLabel

Genotype and Lifetime Burden o ...... ardiomyopathy Registry (SHaRe)

@en

Genotype and Lifetime Burden o ...... Human Cardiomyopathy Registry

@nl

P1476

Genotype and Lifetime Burden o ...... ardiomyopathy Registry (SHaRe)

@en

P2093

Alexandre C Pereira

http://www.w3.org/2001/XMLSchema#string

Allison L Cirino

http://www.w3.org/2001/XMLSchema#string

Carolyn Y Ho

http://www.w3.org/2001/XMLSchema#string

Christine E Seidman

http://www.w3.org/2001/XMLSchema#string

Colleen A Caleshu

http://www.w3.org/2001/XMLSchema#string

Daniel Jacoby

http://www.w3.org/2001/XMLSchema#string

Eric M Green

http://www.w3.org/2001/XMLSchema#string

Euan A Ashley

http://www.w3.org/2001/XMLSchema#string

Franco Cecchi

http://www.w3.org/2001/XMLSchema#string

Gautam Sajeev

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association

Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy.

Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).

European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology.

Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.

Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history

Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression.

P304

1387-1398

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.117.033200

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P50

Francesca Girolami

James S. Ware

Adam S Helms

P577

2018-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30297972

http://www.w3.org/2001/XMLSchema#string

P932

6170149

http://www.w3.org/2001/XMLSchema#string